Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
2024 · Drug Resistance Updates · 32 citations
https://doi.org/10.1016/j.drup.2024.101068
J
Jianxiang Shi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
1.7K
Citations
28
h-index
53
i10-index
Jianxiang Shi is an academic researcher from Kunming University of Science and Technology. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Immunotherapy and Immune Responses & Pancreatic and Hepatic Oncology Research. The author has an h-index of 28, co-authored 116 publications.
ORCID: 0000-0002-4346-3895Papers by this author
worksOptimizing CAR-T cell Culture: Differential effects of IL-2, IL-12, and IL-21 on CAR-T cells
2024 · Cytokine · 14 citations
https://doi.org/10.1016/j.cyto.2024.156758
Glucose deprivation triggers DCAF1-mediated inactivation of Rheb-mTORC1 and promotes cancer cell survival
2024 · Cell Death and Disease · 10 citations
https://doi.org/10.1038/s41419-024-06808-1
Diagnostic Value of Rna for Hepatocellular Carcinoma: A Network Meta-Analysis
2021 · Biomarkers in Medicine · 6 citations
https://doi.org/10.2217/bmm-2021-0327
Single-cell analysis reveals that GFAP+ dedifferentiated Schwann cells promote tumor progress in PNI-positive distal cholangiocarcinoma via lactate/HMGB1 axis
2025 · Cell Death and Disease · 6 citations
https://doi.org/10.1038/s41419-025-07543-x
Screening colorectal cancer associated autoantigens through multi-omics analysis and diagnostic performance evaluation of corresponding autoantibodies
2025 · BMC Cancer · 3 citations
https://doi.org/10.1186/s12885-025-14080-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat